Marie-Émilie Dourthe

Author

Assistance Publique – Hôpitaux de Paris ORCID

Also Known As

Dourthe, Marie Emilie, M E Dourthe, M.-E. Dourthe, M.E. Dourthe, M.‐E. Dourthe, Marie Emilie Dourthe, Marie Émilie Dourthe, Marie-Emilie Dourthe, Marie-Émilie Dourthe, Marie‐Emilie Dourthe

Publications

638

Citations

H-Index

Concepts

All Affiliations

Assistance Publique – Hôpitaux de Paris Institut Necker Enfants Malades Université Paris Cité Hôpital Necker-Enfants Malades Inserm

About

Marie-Émilie Dourthe is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	265
2	Immunology	2	2	206
3	Health Sciences	1	1	19
4	Cell Biology	1	1	61
5	Cellular Therapies	1	1	61

Marie-Émilie Dourthe

Publications

444

Citations

H-Index

Page 1

	Year	Citations
Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia Marie-Émilie Dourthe, Florence Rabian, Karima Yakouben, Leukemia Hematological MalignancyLymphoid NeoplasiaTransplantationMedicineMixed-phenotype Acute Leukemia	2021	145
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study Elad Jacoby, Sara Ghorashian, Britta Vormoor, Leukemia Hematological MalignancyNeuro-oncologyCell TherapyMedicineCd19 Car T-cells	2022	61
Renal outcome in children with antenatal diagnosis of severe CAKUT Julien Hogan, Marie-Émilie Dourthe, Éléonore Blondiaux, Pediatric Nephrology UrologyRenal OutcomeMedicineRenal PathologyPediatrics	2011	40
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL Guillaume P. Andrieu, Milena Kohn, Mathieu Simonin, Blood	2021	36
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins Thomas Steimlé, Marie-Émilie Dourthe, Marion Alcantara, Blood Cancer Journal	2022	33
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients Mathieu Simonin, Loïc Vasseur, Étienne Lengliné, Blood	2024	30
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL Mathieu Simonin, Aline Schmidt, Christophe Bontoux, Journal of Hematology & Oncology	2021	19
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study Marie-Émilie Dourthe, Aurélie Phulpin, Anne Aupérin, Haematologica Hematological MalignancyLymphoid NeoplasiaOncologyMalignant Blood DisorderHematology	2022	19
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia Marion Alcantara, Mathieu Simonin, Ludovic Lhermitte, Blood Advances	2019	16
Management of childhood aplastic anemia following liver transplantation for nonviral hepatitis: A French survey Fanny Delehaye, Dalila Habès, Marie-Émilie Dourthe, Pediatric Blood & Cancer	2020	14

Page 1